News
1d
Zacks Investment Research on MSNWhy Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates AgainLooking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...
3d
Zacks Investment Research on MSNHRMY vs. ILMN: Which Stock Should Value Investors Buy Now?Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Harmony Biosciences Holdings, Inc. (HRMY) and Illumina (ILMN). But which of these two ...
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the 7 most undervalued pot stocks to buy according to analysts. On June 23, Mizuho reiterated its “Outperform” rating on Harmony and ...
HRMY sticks out from ONC in both our Zacks Rank and Style Scores models, so value investors will likely feel that HRMY is the better option right now.
14d
Zacks.com on MSNHere's Why Harmony Biosciences Is an Unconventional Cannabis InvestmentHRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.
Discover Harmony Biosciences Hldgs stock earnings estimates, EPS, and revenue analysis with Benzinga. Stay informed on HRMY's financial performance.
Both HRMY and ACAD are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that HRMY is the superior value option right now.
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Harmony Biosciences Holdings, Inc. (HRMY) and Repligen (RGEN). But which of these ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results